TherapeuticsMD
TXMD
TXMD
137 hedge funds and large institutions have $1.05B invested in TherapeuticsMD in 2016 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 46 increasing their positions, 40 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
137
Holders Change
+14
Holders Change %
+11.38%
% of All Funds
3.66%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
46
Reduced
40
Closed
12
Calls
$4.89M
Puts
$409K
Net Calls
+$4.48M
Net Calls Change
+$655K
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.2M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$10M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$5.46M |
| 4 |
JGC
J. Goldman & Co
New York
|
+$4.78M |
| 5 |
Millennium Management
New York
|
+$3.36M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$69M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$9.02M |
| 3 |
GH
GAM Holding
Zurich,
Switzerland
|
-$6.53M |
| 4 |
JPMorgan Chase & Co
New York
|
-$5.08M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$4.27M |
